Return to revision history
Revision as of 12:13:42, 23 November 2022 by 3.221.77.51
Revision as of 12:13:39, 8 December 2022 by 3.221.77.51
Line 1: Line 1:
Richardson, Department of Medical Oncology, Monash Medical Centre, Clayton, Australia; Dr M <a href=http://stromectol.ink/>achat stromectol</a>
Avoid coadministration of pazopanib with strong CYP3A4 inhibitors if possible; if must coadminister, decrease pazopanib dose to 400 mg day Minor 1 pazopanib and voriconazole both increase QTc interval <a href=http://sviagras.cyou>what is viagra used for</a>